A carregar...
Carfilzomib reverses pulmonary arterial hypertension
AIMS: Pulmonary arterial hypertension (PAH) remains a lethal disease with pronounced narrowing of pulmonary vessels due to abnormal cell growth. Agents that can reduce the pulmonary vascular thickness thus have therapeutic potential. The present study investigated the efficacy of carfilzomib (CFZ),...
Na minha lista:
| Publicado no: | Cardiovasc Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4836627/ https://ncbi.nlm.nih.gov/pubmed/26952044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvw047 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|